| Product Name | Abiraterone Acetate-d4 |
| Product Code | DA-A008-19 |
| Chemical name | Abiraterone Acetate-d4 |
| Synonyms | (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl-d4)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate; (3β)-17-(3-pyridinyl-d4)-androsta-5,16-dien-3-ol, acetate ester; (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol Acetate-d4 (Ester); |
| Impurity | NA |
| CAS Number | 2122245-63-8 |
| Alternate CAS # | NA |
| Molecular form | C26H29D4NO2 |
| Appearance | White Solid |
| Melting Point | NA |
| Mol. Weight | 39.57 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | stable isotopes,impurities,metabolites,pharmaceutical standards,intermediates,Fine Chemicals |
| Boiling Point | NA |
| Applications | Labelled Abiraterone acetate is a novel steroidal inhibitor of human Cytochrome P450(17α-Hydroxylase-C17,20-lyase): potential agent for the treatment of prostatic cancer. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
| NA |
